GENFIT (EPA:GNFT) | WebDisclosure

Basculer en Français

10368	Companies
215965	Keywords
145706	Articles
114373	Press releases

Home
Companies
GENFIT

PRESS RELEASE

published on 02/12/2026 at 18:35, 2 months 23 days ago

GENFIT va recevoir un paiement d’étape de 20 M$ suite au dépassement du seuil des 200 M$ de ventes nettes d’Iqirvo® par Ipsen dès sa première année complète de commercialisation
GENFIT recevra un paiement d'étape de 20 M$ suite au dépassement des ventes nettes d'Iqirvo® par Ipsen, confirmant le lancement d'une Phase 3 dans la PSC et les progrès de l'étude de Phase 1b dans le CCA

Phase 3 Ventes Nettes GENFIT Paiement D'étape Iqirvo
PRESS RELEASE

published on 02/12/2026 at 18:35, 2 months 23 days ago

GENFIT to receive US$20M milestone after Ipsen’s Iqirvo® exceeds the US$200M threshold in its first full year of net sales
GENFIT receives US$20M milestone from Ipsen as Iqirvo® surpasses US$200M net sales threshold in 2025. Phase 3 in PSC confirmed. CCA Phase 1b study progressing as planned. Financial position reinforced

Net Sales Phase 3 GENFIT Milestone Payment Ipsen
BRIEF

published on 11/10/2025 at 07:50, 5 months 27 days ago

GENFIT Collaborates with EVerZom on Exosome-Based Therapy for Liver Failure

GENFIT ACLF EVerZom Exosome Therapy EViv
BRIEF

published on 11/10/2025 at 07:50, 5 months 27 days ago

GENFIT collabore avec EVerZom sur une thérapie à base d'exosomes pour l'insuffisance hépatique

GENFIT ACLF EVerZom EViv Thérapie Par Exosomes
PRESS RELEASE

published on 11/10/2025 at 07:45, 5 months 27 days ago

GENFIT signe un partenariat de recherche avec EVerZom pour faire progresser une technologie de médecine régénérative basée sur les exosomes dans l’ACLF
GENFIT signe un partenariat de recherche avec EVerZom pour avancer la technologie de médecine régénérative basée sur les exosomes dans l’ACLF. Collaboration entre GENFIT et EVerZom dans le domaine de l'ACLF pour les thérapies régénératives

Médecine Régénérative GENFIT ACLF Exosomes EVerZom
PRESS RELEASE

published on 11/10/2025 at 07:45, 5 months 27 days ago

GENFIT Enters Research Collaboration with EVerZom to Advance Exosome-based Regenerative Technology in ACLF
GENFIT collaborates with EVerZom to advance exosome-based regenerative technology in ACLF, aiming for clinical development. The partnership combines expertise in exosome and liver disease research

Exosome GENFIT ACLF EVerZom Regenerative Technology
BRIEF

published on 11/10/2025 at 07:35, 5 months 27 days ago

GENFIT Reveals Encouraging Preclinical Findings on NTZ/G1090N for ACLF Treatment

Preclinical Data GENFIT ACLF Liver Meeting 2025 G1090N
BRIEF

published on 11/10/2025 at 07:35, 5 months 27 days ago

GENFIT révèle des résultats précliniques encourageants concernant le NTZ/G1090N pour le traitement de l'ACLF

GENFIT ACLF Données Précliniques Réunion Du Foie 2025 G1090N
PRESS RELEASE

published on 11/10/2025 at 07:30, 5 months 27 days ago

GENFIT Presents Promising New Preclinical Data on NTZ/G1090N for the Treatment of ACLF at The Liver Meeting® 2025
GENFIT presents promising new preclinical data on NTZ/G1090N for the treatment of ACLF at The Liver Meeting® 2025. G1090N optimizes dosing flexibility for varying patient conditions

Preclinical Data GENFIT NTZ/G1090N ACLF Treatment The Liver Meeting 2025
BRIEF

published on 10/30/2025 at 21:05, 6 months 8 days ago

GENFIT to Delist ADSs from Nasdaq Global Select Market

Euronext Paris Operational Efficiency Nasdaq Delisting GENFIT ADS Deregistration

Accesswire

Published on 05/08/2026 at 00:00, 12 minutes ago

Redwood AI Approved to Receive National Research Council of Canada Funding for its Q-SAFE Chemical Screening Project for Defence and Security Applications
Published on 05/07/2026 at 23:30, 42 minutes ago

Faraday Copper Reports First Quarter 2026 Financial Results
Published on 05/07/2026 at 23:15, 57 minutes ago

BULGOLD Adopts Semi-Annual Financial Reporting
Published on 05/07/2026 at 22:05, 2 hours 7 minutes ago

MicroVision and Avular Collaborate to Advance Autonomous Sensing and Drone Integration for Next-Generation Infrastructure Applications
Published on 05/07/2026 at 22:05, 2 hours 7 minutes ago

Innodata Reports Record First Quarter 2026 Results

View all ACCESSWIRE

EQS Group

Published on 05/07/2026 at 23:23, 48 minutes ago

H1 25/26: Challenging environment and significant changes in IT market // Revised forecast // Programme to boost competitiveness
Published on 05/07/2026 at 23:14, 58 minutes ago

EQS-Adhoc: All for One Group SE revises forecast for 2025/26 financial year // »Precision« programme to boost competitiveness approved
Published on 05/07/2026 at 22:05, 2 hours 7 minutes ago

Univar Solutions Announces Leadership Evolution
Published on 05/07/2026 at 20:42, 3 hours 30 minutes ago

RHÖN-KLINIKUM AG reports stable development in the first quarter of 2026
Published on 05/07/2026 at 18:46, 5 hours 26 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 05/07/2026 at 19:15, 4 hours 57 minutes ago

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 4 hours 57 minutes ago

Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 5 hours 6 minutes ago

Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 5 hours 6 minutes ago

Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 5 hours 12 minutes ago

ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE